ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,515, issued on Oct. 28, was assigned to Tactogen Inc (Palo Alto, Calif.).
"2-aminoindane compounds for mental disorders or enhancement" was invented by Matthew Baggott (Redwood City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses 2-aminoindane Formulas I and II and their pharmaceutically acceptable salts, compositions and methods of use to modulate central nervous system activity, and to treat central nervous system disorders, such as post-traumatic stress, depression, anxiety, and adjustment disorders. In certain embodiments, the compounds of the present invention can be used for entactogenic therapy in counse...